Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Scintigraphic Detection of the Biodistribution of Tumor Necrosis Factor With a Radiolabeled Anti-TNFα in Patients With Active Rheumatoid Arthritis and Active Axial and Peripheral Spondyloarthritis

NCT01590966 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT01590966
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01590966 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Scintigraphic Detection of the Biodistribution of Tumor Necrosis Factor With a Radiolabeled Anti-TNFα in Patients With Active Rheumatoid Arthritis and Active Axial and Peripheral Spondyloarthritis
Lead sponsor
University Hospital, Ghent
Phase
Phase 3
Overall status
Completed
Start date
October 18, 2012
Completion date
August 20, 2019
Enrollment
41 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

axial and peripheral spondyloarthritis, rheumatoid arthritis